{HEAD ~ Compounds} of Formula I ##STR1## are disclosed as {TAIL ~ inhibitors} having activity against the aspartyl proteases, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and Alzheimers disease 
are disclosed as
{ HEAD ~ Compounds } of Formula I # # STR1 # # are disclosed as { TAIL ~ inhibitors } having activity against the aspartyl proteases , plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and Alzheimers disease
HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH REL REL REL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH